Eli Lilly EBITDA 2010-2024 | LLY

Eli Lilly EBITDA for the quarter ending December 31, 2024 was $2.372B, a 1288.48% decline year-over-year.

  • Eli Lilly 2024 EBITDA was 14.666B, a 83.66% increase from 2023.
  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Eli Lilly EBITDA 2010-2024 | LLY

  • Eli Lilly 2024 EBITDA was 14.666B, a 83.66% increase from 2023.
  • Eli Lilly 2023 EBITDA was 7.985B, a 7.68% decline from 2022.
  • Eli Lilly 2022 EBITDA was 8.65B, a 9.43% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B